Finance

Lists
Why is UNCY down ७.२५%?
Dive Deeper
UNCY:NASDAQ
Unicycive Therapeutics Inc
US$ ४.२२
-७.२५%
(-०.३३) 1D
US$ ४.२३
+०.२४% (+०.०१०)
After hours
Closed: अक्टोबर २, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UNCY...
Open
US$ ४.६२
High
US$ ४.६२
Low
US$ ४.०९
Mkt. cap
११.७५ करोड
Avg. vol.
८.३२ लाख
Volume
१५.१० लाख
52-wk high
US$ ८.७४
52-wk low
US$ ३.९९
EPS
-US$ १.६२
Beta
१.८३
Shares outstanding
२.७९ करोड
No. of employees
२२
Open
US$ ४.६२
High
US$ ४.६२
Low
US$ ४.०९
Mkt. cap
११.७५ करोड
Avg. vol.
८.३२ लाख
Volume
१५.१० लाख
52-wk high
US$ ८.७४
52-wk low
US$ ३.९९
EPS
-US$ १.६२
Beta
१.८३
Shares outstanding
२.७९ करोड
No. of employees
२२
News stories
From web sources and news partners
About Unicycive Therapeutics Inc
CEO-
Employees२२
Founded२०१६
Headquarters-
Sector-
Websiteunicycive.com
Analyst ratings
Based on 6 analysts giving stock ratings to UNCY in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for UNCY in the last 3 months.
Highest
Current US$ ४.२२
US$ ५०.०० (+१,०८४.८३%)
Average
US$ २५.५० (+५०४.२७%)
Lowest
US$ १३.०० (+२०८.०६%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
US$ १३.००
+२०८.१%
09/30/2026
Bruce Jackson
StoneX
Buy
Maintained
US$ १५.००
+२५५.५%
08/20/2026
Jason McCarthy
Maxim Group
Buy
Maintained
US$ ३०.००
+६१०.९%
08/17/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
US$ २०.००
+३७३.९%
08/13/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
US$ ५०.००
+१,०८४.८%
08/13/2026
Vamil Divan
Guggenheim
Buy
Maintained
US$ २५.००
+४९२.४%
08/12/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
US$ ९०.००
+२,०३२.७%
06/01/2026
Unknown Analyst
Westpark Capital
Buy
Initiated
US$ ७२.००
+१,६०६.२%
02/19/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
२९.६४ लाख
२२.५० लाख
१६.०७ लाख
२७.८८ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४३.७८ लाख
४९.७४ लाख
६८.३० लाख
७३.५२ लाख
Operating expense
७३.४२ लाख
७२.२४ लाख
८४.३७ लाख
१.०१ करोड
Total operating expenses
७३.४२ लाख
७२.२४ लाख
८४.३७ लाख
१.०१ करोड
Operating income
-७३.४२ लाख
-७२.२४ लाख
-८४.३७ लाख
-१.०१ करोड
Other non operating income
१०.६७ लाख
-७७.६८ लाख
-४७.८० लाख
७९.७७ लाख
EBT including unusual items
-६०.११ लाख
-१.४७ करोड
-१.२८ करोड
-१७.२२ लाख
EBT excluding unusual items
-६०.११ लाख
-१.४७ करोड
-१.२८ करोड
-१७.२२ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-६०.११ लाख
-१.४७ करोड
-१.२८ करोड
-१७.२२ लाख
Net profit margin
-
-
-
-
Earnings per share
-०.३३
-०.८२
-०.५४
-०.०६
Interest and investment income
२.७९ लाख
३.५१ लाख
३.९४ लाख
४.४१ लाख
Interest expense
-१५.०० हजार
-२७.०० हजार
-
-
Net interest expenses
२.६४ लाख
३.२४ लाख
३.९४ लाख
४.४१ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-७३.३२ लाख
-७२.१४ लाख
-८४.२९ लाख
-१.०१ करोड
Gain or loss from assets sale
-
-
१८.०० हजार
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू